Abstract:BackgroundThe discovery of novel anticancer drugs is critical for the pharmaceutical research and development, and patient treatment. Repurposing existing drugs that may have unanticipated effects as potential candidates is one way to meet this important goal. Systematic investigation of efficient anticancer drugs could provide valuable insights into trends in the discovery of anticancer drugs, which may contribute to the systematic discovery of new anticancer drugs.ResultsIn this study, we collected and analyzed 150 anticancer drugs approved by the US Food and Drug Administration (FDA). Based on drug mechanism of action, these agents are divided into two groups: 61 cytotoxic-based drugs and 89 target-based drugs. We found that in the recent years, the proportion of targeted agents tended to be increasing, and the targeted drugs tended to be delivered as signal drugs. For 89 target-based drugs, we collected 102 effect-mediating drug targets in the human genome and found that most targets located on the plasma membrane and most of them belonged to the enzyme, especially tyrosine kinase. From above 150 drugs, we built a drug-cancer network, which contained 183 nodes (150 drugs and 33 cancer types) and 248 drug-cancer associations. The network indicated that the cytotoxic drugs tended to be used to treat more cancer types than targeted drugs. From 89 targeted drugs, we built a cancer-drug-target network, which contained 214 nodes (23 cancer types, 89 drugs, and 102 targets) and 313 edges (118 drug-cancer associations and 195 drug-target associations). Starting from the network, we discovered 133 novel drug-cancer associations among 52 drugs and 16 cancer types by applying the common target-based approach. Most novel drug-cancer associations (116, 87%) are supported by at least one clinical trial study.ConclusionsIn this study, we provided a comprehensive data source, including anticancer drugs and their targets and performed a detailed analysis in term of historical tendency and networks. Its application to identify novel drug-cancer associations demonstrated that the data collected in this study is promising to serve as a fundamental for anticancer drug repurposing and development.

Comprehensive Analysis Of Cancer Drugs Based On Human Protein-Protein Interaction Network Profiles Of These Targets

Learning the Drug Target-Likeness of A Protein

Enhancing Cancer Driver Gene Prediction by Protein-Protein Interaction Network

Drug Screening and Biomarker Gene Investigation in Cancer Therapy Through the Human Transcriptional Regulatory Network

Artificial intelligence in cancer target identification and drug discovery

Protein-protein interaction: a novel direction for discovering anti-tumor drugs

Identification of the Key Target Profiles Underlying the Drugs of Narrow Therapeutic Index for Treating Cancer and Cardiovascular Disease

Systems pharmacology strategies for anticancer drug discovery based on natural products.

Predicting Enzyme Targets for Cancer Drugs by Profiling Human Metabolic Reactions in NCI-60 Cell Lines

Drug Target Protein-Protein Interaction Networks: A Systematic Perspective

A systematic analysis of FDA-approved anticancer drugs

Determining the Balance Between Drug Efficacy and Safety by the Network and Biological System Profile of Its Therapeutic Target

Identifying Potential Drug Targets in Hepatocellular Carcinoma Based on Network Analysis and One-Class Support Vector Machine.

The Human Kinome Targeted by FDA Approved Multi-Target Drugs and Combination Products: A Comparative Study from the Drug-Target Interaction Network Perspective

Quantitative and Systems Pharmacology. 1. in Silico Prediction of Drug-Target Interactions of Natural Products Enables New Targeted Cancer Therapy.

Synthetic Lethality-based Identification of Targets for Anticancer Drugs in the Human Signaling Network

A Comparative Study of Cluster Detection Algorithms in Protein-Protein Interaction for Drug Target Discovery and Drug Repurposing

Identifying network biomarkers based on protein-protein interactions and expression data

The Discovery of New Drug-Target Interactions for Breast Cancer Treatment

DrugComboRanker: Drug Combination Discovery Based on Target Network Analysis

Identifying Drug Targets in Pancreatic Ductal Adenocarcinoma Through Machine Learning, Analyzing Biomolecular Networks, and Structural Modeling.